J&J mulls sale of diagnostics unit

(Reuters) - Johnson & Johnson may sell or spin off its slow-growing $2 billion-a-year diagnostics business, the company said on Tuesday when it reported quarterly earnings.

Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/FIXgVbBlVns/us-jj-results-idUSBRE90L0H520130122

chiropody courses phlebotomy courses in toronto phlebotomy training oklahoma